On 12 February 2026, WuXi XDC Cayman Inc. (the “Offeror”) and BioDlink International Company Limited (“BioDlink International,” stock code: 1875) issued a composite offer and response document outlining an Option Offer for the cancellation of certain share options. Under the terms presented, holders may surrender share options—exercisable at HK$2.2335 per share option—in exchange for HK$1.7665 in cash per option.

Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited, and Hong Kong Securities Clearing Company Limited disclaim responsibility for the contents of the pink form of Option Offer Acceptance, noting no representation as to its accuracy or completeness. Holders who wish to accept must complete the required form and submit relevant documentation to the company’s specified registrar by 4:00 p.m. on 13 March 2026, or by the later time(s) or date(s) the Offeror may announce in accordance with the Takeovers Code.

The pink form sets forth detailed conditions for acceptance and cancellation of the share options. It also reiterates the need for holders, especially those overseas, to ensure compliance with local regulatory requirements and to shoulder any associated taxes. Interested parties are advised to consult the composite document issued on 12 February 2026 for full terms and conditions governing the Option Offer.